809 — Global Bio-chem Technology Co Cashflow Statement
0.000.00%
Last trade - 00:00
- HK$792.76m
- HK$5.10bn
- HK$1.37bn
C2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | — |
Source: | ARS | ARS | ARS | ARS | |
Standards: | HKAS | HKAS | HKAS | — | — |
Status: | Final | Final | Final | Final | fx Preliminary |
Net Income/Starting Line | -1,077 | -2,411 | -409 | -1,574 | — |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | -34 | 1,361 | -507 | 741 | — |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 1,011 | 566 | 38.4 | 414 | — |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 405 | -26.2 | -475 | -88 | — |
Capital Expenditures | -51.4 | -16.8 | -25.8 | -6.18 | — |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -1.04 | 137 | 418 | 5.76 | — |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -52.5 | 120 | 393 | -0.413 | — |
Financing Cash Flow Items | -374 | -95.3 | -58 | -12.1 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -457 | -25.9 | -48.7 | 110 | — |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -55.5 | 73.8 | -132 | 20 | — |